Geneleukim Injection 300mcg

About Geneleukim Injection 300mcg

Geneleukim Injection Uses

• Reducing the risk of infection in patients with neutropenia after chemotherapy
• Supporting white blood cell recovery following bone marrow transplant
• Managing chronic severe neutropenia in certain blood disorders
• Mobilizing stem cells into the bloodstream before stem cell collection

Geneleukim Injection Benefits

• Shortens the duration of low white blood cell counts after cancer treatment
• Lowers the chances of severe infections during chemotherapy cycles
• Helps patients stay on schedule with planned chemotherapy doses
• Supports faster immune recovery after a bone marrow transplant

What Experts Say

Oncologists prescribe filgrastim, the active ingredient in Geneleukim Injection, to counter chemotherapy induced neutropenia, a drop in infection fighting white blood cells that raises the risk of serious infection. As a recombinant growth factor, it signals bone marrow to produce and release neutrophils faster than the body would on its own.

Dosing is calculated by body weight and timed carefully after chemotherapy, usually starting a day or more after the cycle ends and continuing until blood counts recover to a safe range. Doctors monitor complete blood counts closely during treatment, since starting too early or stopping too soon can blunt the intended benefit.

Pakistan carries a significant burden of hematologic and solid organ cancers where dose intensive chemotherapy is standard, making growth factor support an important tool for keeping treatment on schedule. Physicians weigh the cost and injection burden against the real reduction in febrile neutropenia episodes it provides.

Drug Class

• Granulocyte Colony Stimulating Factor (G-CSF)

Geneleukim Injection 300mcg formula

• Filgrastim

Available forms

• Injection

How to use Geneleukim Injection 300mcg?

• Administer this injection only under the supervision of a doctor or trained healthcare provider.
• Give as a subcutaneous or intravenous infusion exactly as prescribed for the intended cycle.
• Do not shake the vial vigorously before use.
• Allow the injection to reach room temperature before administration to reduce discomfort.
• Complete the full course as directed even if blood counts appear to improve early.

Drug Interactions

• Lithium: May increase the release of neutrophils and intensify Filgrastim's effect on white blood cell counts.
• Chemotherapy Drugs: Should not be given in the 24 hours before or after cytotoxic chemotherapy since rapidly dividing cells are more sensitive during this period.
• Radiation Therapy: Concurrent use with radiation may increase the risk of low platelet counts.

Risks and warnings

• Bone Pain: Filgrastim commonly causes mild to moderate bone pain as it stimulates bone marrow activity.
• Spleen Enlargement: Rare cases of splenomegaly or rupture have been reported, requiring prompt attention for left upper abdominal pain.
• Allergic Reactions: Serious hypersensitivity reactions including rash, swelling and breathing difficulty can occur.
• Sickle Cell Crisis: Patients with sickle cell disease may experience severe crises during treatment.
• Acute Respiratory Reactions: Rare pulmonary reactions such as cough and fever with breathing difficulty have been documented.

Geneleukim Injection Side Effects

• Bone or muscle pain
• Headache
• Nausea
• Fatigue
• Injection site redness or irritation
• Low grade fever
• Elevated liver enzymes on blood tests
• Rare allergic skin reactions

Storage Conditions

• Store in a refrigerator between 2°C and 8°C, do not freeze.
• Keep the vial in its outer carton to protect from light.
• Avoid shaking the vial vigorously during handling.
• Discard any unused portion after a single use, do not reuse the vial.
• Keep out of reach of children.